AGYS

Agilysys, Inc. · NASDAQ

News

3 latest

Zacks Investment Research

Agilysys (AGYS) Reports Q2 Earnings: What Key Metrics Have to Say

Agilysys (AGYS) reported Q3 2026 revenue of $93.36 million, up 17.7% year-over-year, beating consensus estimates by 2.21%. EPS of $0.67 exceeded expectations of $0.55 by 21.82%.

Zacks Investment Research

HPE vs. AGYS: Which Stock Is the Better Value Option?

Hewlett Packard Enterprise (HPE) is positioned as the superior value investment compared to Agilysys (AGYS) based on valuation metrics and earnings outlook. HPE has a Zacks Rank of #2 (Buy) with a forward P/E of 14.88 and PEG ratio of 0.44, while AGYS carries a Zacks Rank of #3 (Hold) with a forward P/E of 50.08 and PEG ratio of 2.50. HPE received a Value grade of B versus AGYS's F grade.

Zacks Investment Research

Gear Up for Agilysys (AGYS) Q2 Earnings: Wall Street Estimates for Key Metrics

Wall Street analysts forecast Agilysys will report Q2 earnings of $0.55 per share, representing a 37.5% year-over-year increase, with revenues expected at $91.34 million, up 15.2% from the prior year quarter. Key revenue segments include subscription and maintenance services projected at $61.72 million (+21.1% YoY), professional services at $19.43 million (+6.5% YoY), and products at $10.08 million (-0.2% YoY). The stock has gained 16% over the past month and carries a Zacks Rank #3 (Hold) rating.

Headlines link to the publisher. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.